week 7- Mental Health and Affective Disorders Sway Flashcards

(42 cards)

1
Q

what are are risk factors for depressive diorders?

A

-stress
-chronic stress increases cortisol release from adrenal cortex due to CRH produced in the hypothalamus (HPA axis)
• Genetic factors – high heritability of depressive disorders in twin
studies
• Family history
• Intensive efforts made to find genes linking to depression but GWAS
have given few clues
• Candidate gene studies have identified ~200 genes, SLC6A4 is one
• Substance abuse

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

what is the first theory for the pathophysicology of depression? what it means?

A

-monamine theory
-If we identify the cause of depression = we can effectively treat it
-there was a functional deficit of monoamine
neurotransmitters (5-HT and noradrenaline) and dopamine in areas of the brain
-

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

what is the effect of Tricyclic antideppressants and how do they work?

A

Block monoamine reuptake Enhance mood

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

what is the effect of MAO inhibitors and how do they work?

A

Prevent degradation of
monoamines
Enhance mood

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

what is the effect of tryptophan and how do they work?

A

Increase 5-HT synthesis

enhance mood

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

what is the effect of reserpine and how do they work?

A

Inhibit monoamine storage Reduce mood

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

what is the effect of α-Methyltyrosine and how do they work?

A

Inhibit noradrenaline synthesis

Reduce mood

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

what is the effect of Methyldopa and how do they work?

A

Inhibit noradrenaline synthesis

Reduce mood

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

what neurotransmitters can cause depression?

A

NA and 5-HT (SEROTONIN)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

what are the drug targets for depressive disorders?

A
  • the reuptake transporers for both 5-HT and NA
  • they are in the SLC6 family
  • known as SERT and NET
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

what does SERT stand for?

A

seretonin reuptake transporters

-SLC6A4

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

what does NET stand for?

A

Norarenaline reuptake transporters

-SLC6A2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

what type of transporter is SERT and NET?

A

-symporters
-use co-transporter of sodium as a driving force for carrying their substrate (neurotransmitter) across the plasma membrane
-• Dependent on extracellular Cl-
• Some SLC transporters also move K+

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

what is the structure of SERT?

A
• 12 transmembrane domains• Intracellular N and C-termini• Large glycosylated EC loop
between TM3 and 4
• Alternating access model
• Substrate binding site is
accessible to either the
external or internal medium
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

how is the substrate is moved across the plasma membrane through SERT?

A
  • substrate and Na+ comes in
  • it becomes bound and occuluded
  • then transporter opens and the substate and counter transporter ion is rleased
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

where are SERT and NET found?

A

on the pre synatic terminals of the seretinergic and noradrenergic neurones

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

how do reuptake inhibitors work/

A

-only work once the neurotrasmitters have been released
• Prevent the reuptake of serotonin or NA into the neurons
• Enhances the synaptic levels of serotonin and/or noradrenaline within the synapse and lengthen the amount of time the Neurotrasmitter is avavliable to then bind to the receptor on the post synpatic neuron

18
Q

what are some examples of of anti-depressants?

A

• SSRIs:
Fluoxetine, paroxetine, sertraline, citalopram, escitalopram, fluvoxamine
• SNRIs:
Buproprion, reboxetine, atomoxetine
• Mixed (non-selective both):
Venlafaxine, duloxetine
• Tricyclic antidepressants (non selective)
Imipramine, desipramine(selective for NA), amitryptyline, clomipramine

19
Q

what does SSRI mean?

A

selective serotonin reuptake

inhibitors

20
Q

what does SNRI mean?

A

serotonin & noradrenaline

reuptake inhibitors

21
Q

WHAT ARE THE CONSEQUENCES OF INCREASED 5-HT AND NA?

A

• Increased signalling through 5-HT receptors and NA receptors
- Pre-synaptic and post-synaptic
• Gene expression changes, neurogenesis – chronic adaptive changes

22
Q

how is controlling serotonin levels with reuptake inhibitors?

A

• Acute action – increases synaptic 5-HT by reducing reuptake
• But 5-HT acts on 5-HT1A on soma/dendrites to inhibit 5-HT release
• This cancels out some of the effect of SSRIs
• Chronic administration – elevated 5-HT level will induce
desensitisation of 5-HT1A receptors
• This in turn will reduce the inhibitory effect of 5-HT
• This need for desensitisation could explain the slow onset of action

23
Q

how is NA controling 5-HT levels?

A

• Noradrenaline can control 5-HT release
• NA can act on excitatory α1
receptors to enhance 5-HT release
• α2 receptors are downregulated by antidepressants
• α2 receptor antagonists could
further enhance 5-HT releasee.g. mirtazapine, mianserin

24
Q

what is monoamine oxidase (MAO)

A

• Monoamine Oxidase (MAO) controls the degradation of monoamine
neurotransmitters
• There are two forms of MAO –A and B(dopamine preference)
• MAO-A has substrate preference for 5-HT and NA
• Inhibitors of this enzyme will cause an increase in tissue monoamines (5-HT, NA, Dopamine)

25
how do MAO inhibitors work?
• Increase cytoplasmic stores of noradrenaline and 5-HT in nerve terminals • Irreversible non-competitive inhibitors – e.g. phenelzine, iproniazid • Most are non-selective for different forms of MAO • Reversible MAO-A selective inhibitors – moclobemide • Can be increase in spontaneous release of neurotransmitter and increase in release by sympathomimetic amines (e.g.tyramine)
26
what are some side effects of MAO Inhibitor?
- Hypotension – common side effect - Central stimulation – tremors, excitement, insomnia - Increased appetite causing weight gain - Drug & food interaction – the cheese reaction • Ingestion of tyramine in foods such as ripe cheese and marmite • Typically degraded in gut by MAO • With MAOI – tyramine absorbed into circulation and has sympathomimetic effect • Acute hypertension and severe headaches
27
what is the neuroendocrine mechanism?
-stimulation of the hypothalmus causes the release of CRF -CRF which then acts on on the piturity gland which then releases ACTH which then acts on the adrenal cortex which releases gluccorticosteriod • Increased plasma cortisol levels in severe depression • Impaired glucocorticoid induced feedback control • Injection of CRH (CRF) into brain can mimic aspects of depression • Cushing’s syndrome – often causes depression • No current clinical intervention
28
why are gluccorticosteriod important?
-they regulate the brain
29
what is the inflammatory mechanism in causing depression?
-comes from sickness behaviour • Behavioural changes experienced with infections can mimic depressive-like behaviour • Cytokines cause these changes • Infusion of particular cytokines induces depression in humans and rodents • IL-2 and IFN-γ • People with autoimmune disease more likely to have depression • Post-mortem evidence of microglial activation in patients with depression
30
what is the structural changes in the brain?
• Regional specific neuronal cell loss, changes in synaptic activity causing the imbalances in neurotransmitters • Functional imaging studies show a decrease in gray matter volume in pre-frontal cortex and hippocampus • Smaller volume of important brain structures • Post-mortem studies conform a loss in GABAergic neurons, astrocytes and oligodendrocytes in the pre-frontal cortex
31
what is the neuroplasticity and neurogenesis?
• Neurogenesis – formation of new neurons from pluripotent stem cells • Neuroplasticity – growth and adaptability of neurons • Neurogenesis is controlled by trophic factors such as BDNF • Humans – reduced BDNF in CSF of patients • Antidepressants can raise BDNF levels • In animal models reducing neurogenesis can prevent the action of antidepressants • injection of BDNF has an antidepressant effect
32
what is esketamine?
``` • Ketamine derivative • No delay in the anti-depressant effect of esketamine • NMDA receptor non-competitive channel blocker • Approved by EMA for treatmentresistant depression in 2019 • Proposed mechanism: blocking NMDA receptors on GABA interneurons prevents tonic activity – causes a glutamate surge which increases BDNF signalling ```
33
what are some problems with antidepressants?
• Do not work in everybody • Side effects for SSRIs include nausea, insomnia, sexual dysfunction, paroxetine linked to increased suicidality, risk of drug interactions CYP • Tricyclics can have a sedating effect, anticholinergic effects, confusion, motor incoordination effect, higher risks with overdose • SNRIs side effects include sedation, dizziness, nausea and some can have withdrawal effect • Monoamine oxidase inhibitors (MAOI) side effects include CNS stimulation, weight gain, insomnia, postural hypotension • Major problem with MAOI is the cheese reaction – tyraminecontaining foods – increased tyramine causes sympathomimetic effect (acute hypertension, headache)
34
what are the two types of bipolar?
• Bipolar I (episodes of mania) and bipolar II (episodes of | hypomania and depression)
35
what is the pathophysiology of bipolar disorder?
• Pathophysiology involves dendritic spine loss, altered cellular connectivity and neural plasticity
36
what is some treatment for bipolar disorder?
• Stabilisation of mood is the overall goal • Lithium - taken orally as lithium carbonate • Used in prophylaxis and treatment of mania • Carbamazepine, valproate and lamotrigine anti-epileptic drugs can be used• Quetiapine, olanzepine and other anti-psychotic drugs can be used • Benzodiazepines can be used for calming effect • Use of anti-depressants is not recommended – can lead to switching to manic phase
37
how does lithium work in bipolar disorder?
``` • Lithium is a monovalent cation • Lithium is thought to accumulate inside cells, cause inhibition of inositol phosphate pathway and inhibition of GSK3 affecting cellular responses -accumulates as it isnt pumped out the cells through sodium potassium symporter ```
38
what antiepileptic drugs can be used to treat bipolar disorder?
• Carbamazepine, valproate and lamotrigine – affect NaV channels • Blocking action on NaV channels prevents action potential generation • These drugs show use dependence therefore more activity is seen with higher firing rates (e.g. in epilepsy) • Lamotrigine has a broader mechanism of action – also affects neurotransmitter release and may have activity on CaV channels • Mechanism of action in bipolar disorder – due to reduction in neuronal excitation• Better side effect profile than lithium
39
what atypical antipsychotics can be used to treat bipolar disorder?
* Olanzepine, quetiapine, risperidone, aripiprazole – act as antagonists at D2 and 5-HT2A receptors * Also may have activity at several other receptors including α1, H1, 5-HT1Aand mAChR * Second generation antipsychotics * Effective against treatment of mania
40
what are anxiety disorders?
``` • Chronic disorder • Depression is often co-morbid with anxiety • Clinical recognised anxiety states include: - Generalised anxiety disorder (GAD) - Social anxiety disorder - Phobias - Panic disorder - PTSD - OCD ```
41
what are the pathophysiology of anxiety disorders?
• Anxiety arises from an abnormal regulation of fear response • Fear – subjective response to threatening stimulus • Anxiety is longer lasting and can persist due to lack of signs of safety • Disorders are distinguished based on • symptoms • precipitating factors • Genetic component – run in families • Amygdala is activated by induction of fear – neuroimaging suggests patients have heightened activity in amygdala circuits
42
what is the treatment for anxiety disorder?
• Psychological approaches are used as well as medication • Main drugs used: 1. Antidepressants (SSRIs, SNRIs) – increase 5HT and NA levels • E.g. Escitalopram and paroxetine, venlafaxine, duloxetine 2. Benzodiazepines – enhance action of GABA on GABAA receptors containing α2 subunit e.g. lorazepam, diazepam, flurazepam Benzodiazepine side effects are sedation, confusion, tolerance and dependence 3. Buspirone (5HT1A receptor agonist) – can be used to treat generalised anxiety disorder • 5HT1A receptors can act as inhibitory autoreceptors on serotonergic neurons, postsynaptic 5HT1A receptors are involved in emotional behaviour 4. Gabapentin, pregabalin, valproate – affect NaV and CaV channels – anxiolytic properties 5. Atypical antipsychotics – olanzepine, quetiapine – can be effective in GAD and PTSD 6. Propranolol - a β-blocker which can be used for relief of situational anxiety, GAD 7. Non-pharmacological treatments: Counselling Cognitive therapy Dietary and lifestyle changes